glp-1+gip Biology of Incretins: GLP-1 and GIP GLP-1/GIP+B12 - Aulcare MD

Huberman suggests potential bans may have less to do with safety and more to do with protecting pharmaceutical patents

Exposures Two cohorts were assembled, with the first composed of patients who started and continued on GLP-1 receptor agonists or DPP-4 inhibitors between 1 January 2007 and 31 December 2020 and the second composed of patients who started and continued on GLP-1 receptor agonists or SGLT-2 inhibitors between 1 January 1 2013 and 31 December 2020

SUMMARYIncretin therapy is based on the antidiabetic actions of the incretin hormone GLP-1

People taking GLP-1 weight loss medications have found some easy ways to get in lots of protein at meals and snacks.

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are a relatively new class of ...